MedPath

A Randomised Controlled Trial Comparing Bone Anchored Hearing Aid With Bonebridge

Not Applicable
Completed
Conditions
Hearing Loss, Conductive
Bone Conduction Deafness
Interventions
Device: Bone Anchored Hearing Aid
Device: Bonebridge
Registration Number
NCT01858246
Lead Sponsor
Ninewells Hospital
Brief Summary

The Bonebridge is a new bone conducting implantable hearing aid. The investigators plan to randomize patients to receive either the Bonebridge or a conventional bone conducting hearing device. The investigators will then compare the surgical and audiological outcomes of the two groups.

Detailed Description

The new Bonebridge fully implanted, except for an external sound processor. It does not have any percutaneous parts like the Bone Anchored Hearing Aid. The investigators believe that this may improve wound healing and reduce problems with wound infection and skin overgrowth seen in Bone Anchored Hearing Aids.

There may also be audiological improvements by the use of the Bonebridge as the physical separation of the vibrating part from the sound processor should reduce feedback. The company also claims other audiological improvements in the Bonebridge.

The investigators wish to demonstrate whether this is actually the case by performing a study directly comparing the outcomes of the two groups.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
3
Inclusion Criteria
  • Conductive Hearing Loss within criteria for Bonebridge
  • Adults
Read More
Exclusion Criteria
  • Children
  • Pregnancy
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Bone Anchored Hearing AidBone Anchored Hearing AidImplantation with a Bone Anchored Hearing Aid
BonebridgeBonebridgeImplantation with a Bonebridge
Primary Outcome Measures
NameTimeMethod
Speech audiogram result at 6 months after switch on at 60 dBA in quiet using AB word listsUp to 1 year post-operatively

We will record and compare the standard speech audiometry results at a specific sound level in order to make a direct comparison of devices

Secondary Outcome Measures
NameTimeMethod
Speech audiogram result at 60 dB A in noise using AB word listsUp to 1 year after implantation

The speech audiogram will also be carried out in noise to demonstrate whether one device gives an appreciable advantage over another with respect to understanding in noise compared to silence.

Patient reported outcome dataUp to 1 year following implantation

Patients will be asked to complete the Glasgow Benefit Inventory (GBI) and Hearing Device Satisfaction Scale (HDSS) questionnaires

Time from surgery to device switch-onUp to 3 months

The time (measured in days) will be recorded from the date of implantation to the date of its switch-on.

Number of patient episodes required during study period1 year from implantation
Time to complete wound healingUp to 3 months from implantation

Measured in days, as judged subjectively by ENT medical and nursing staff

Trial Locations

Locations (1)

Ninewells Hospital and Medical School

🇬🇧

Dundee, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath